To hear about similar clinical trials, please enter your email below
Trial Title:
Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation
NCT ID:
NCT06328699
Condition:
Lymphoma
Multiple Myeloma
Conditions: Official terms:
Multiple Myeloma
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Spiritual Therapy
Description:
Undergo chaplain led compassionate centered spiritual health sessions
Arm group label:
Arm I (Chaplain delivered compassion meditation)
Intervention type:
Other
Intervention name:
Best Practice
Description:
Receive a traditional chaplain consultation and will receive care upon request
Arm group label:
Arm II (Traditional chaplain consultation)
Other name:
best practice, standard of care, standard of care, standard therapy
Summary:
This clinical trial tests the feasibility, implementation and acceptability of chaplain
delivered compassion meditation in order to improve spiritual care for patients receiving
stem cell transplantation. Hospital chaplains play a vital role in delivering emotional
and spiritual care to a broad range of both religious and non-religious patients for a
wide variety of stressors, and extensive research indicates that spiritual consults
impact patient outcomes and satisfaction. Compassion meditation is a secularized,
research-based mindfulness and compassion meditation program designed to expand and
strengthen compassion for self and others. Practices include training in attentional
stability and increased emotional awareness, as well as targeted reflections to
appreciate one's relationship with self and others. By centering the mind, controlling
debilitating ruminative thoughts, and cultivating personal resiliency and an inclusive
and more accurate understanding of others. Engaging in chaplain delivered compassion
meditation may improve the spiritual care for patients receiving stem cell
transplantation.
Detailed description:
PRIMARY OBJECTIVE:
I. To examine the feasibility, adoption, extent of implementation, acceptability and
fidelity of chaplain-delivered compassion-centered spiritual health (CCSH).
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive chaplain-led compassionate centered spiritual health sessions
over 30 minutes, twice per week for up to 2 weeks.
ARM II: Patients receive a traditional chaplain consultation and care upon request, per
standard of care.
After completion of study treatment, patients are followed up at 80-100 days and 6 months
post treatment.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- PATIENT: Within 6 weeks of scheduled hematopoietic stem cell transplant (HSCT)
- PATIENT: > 18 years of age
- PATIENT: Speak and read English
- CHAPLAIN: Emory Healthcare chaplain
Exclusion Criteria:
- PATIENT: Patients will be excluded if they are cognitively impaired, on a
ventilator, or are in a room requiring enteric precautions or airborne precautions
(e.g., use of an N-95 mask requiring fit-testing) to enter
- CHAPLAIN: There will be no exclusion criteria and no consequence to the chaplains
for refusing to volunteer
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Emory University Hospital/Winship Cancer Institute
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Recruiting
Contact:
Last name:
Erin Brauer, MPH
Email:
erin.graf.brauer@emory.edu
Start date:
October 30, 2023
Completion date:
November 15, 2026
Lead sponsor:
Agency:
Emory University
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Collaborator:
Agency:
National Center for Complementary and Integrative Health (NCCIH)
Agency class:
NIH
Source:
Emory University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06328699